All insights
PONTEM ONE · READOUT 10/16 3 JUN 2026
StrategyPontem One · 4 min read · 3 Jun 2026

Why we run the Second Read platform on profit-share instead of retainer

When revenue depends on patients actually served, every internal argument gets settled by the same question.

Listen to this piece
4:00
MP3 128k
#pod-article-profit-share
Article hero1600×900
Strategy — article lead image 16:9 · WebP/AVIF · ≤180KB · #img-hero-profit-share

Most agencies work on retainer, which means outputs are the deliverable and patient volume is structurally somebody else's problem. The Second Read platform is run differently, deliberately.

The arrangement

Pontem One built nuclearmedicinetherapy.in end to end — technology, SEO, content, schema, UX — and continues to operate it. The consultants provide clinical expertise and deliver the reports. Revenue is split, and our share moves with the number of patients the platform actually serves.

Why we set it up that way

It settles internal arguments. Every decision resolves against one question: does this help a real patient find this service?

It tests the framework on ourselves first. If the 6C Model produces patients, a profit-share should be viable. If it does not, we should be the ones absorbing that, not a client.

It changes what the doctors are buying. Dr. Sen and Dr. Malik are not paying an agency and hoping. They are working with a team whose revenue is contingent on the same outcome theirs is.

When it does not make sense

Profit-share needs measurable patient acquisition, end-to-end platform control, and a long horizon. Most practices have none of the three, and for them retainer or project pricing is the honest structure — we say so.

Want this applied to your own site?

The audit covers the same ground on your domain: crawl, entity graph, and fifty live queries across four answer engines.

Request an audit